Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Free Subscription


2 Cephalalgia
3 Headache
1 Neurology
1 Rev Neurol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. ALPUENTE A, Tassorelli C, Diener HC, Silberstein SD, et al
    Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? Laying the ground for the 4th edition.
    Cephalalgia. 2020 Feb 14:333102420906843. doi: 10.1177/0333102420906843.
    PubMed     Text format     Abstract available

  2. BORTE S, Zwart JA, Skogholt AH, Gabrielsen ME, et al
    Mitochondrial genome-wide association study of migraine - the HUNT Study.
    Cephalalgia. 2020 Feb 14:333102420906835. doi: 10.1177/0333102420906835.
    PubMed     Text format     Abstract available


  3. STUBBERUD A, Tronvik E, Olsen A, Gravdahl G, et al
    Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study.
    Headache. 2020 Feb 13. doi: 10.1111/head.13772.
    PubMed     Text format     Abstract available

  4. LEWIS R, Ruiz A, Monteith T
    Reversible Lesion of the Corpus Callosum in a Patient With Migraine With Aura: A Case Study.
    Headache. 2020 Feb 11. doi: 10.1111/head.13768.
    PubMed     Text format     Abstract available

  5. WINNER PK, Kabbouche M, Yonker M, Wangsadipura V, et al
    A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine.
    Headache. 2020 Feb 9. doi: 10.1111/head.13754.
    PubMed     Text format     Abstract available


  6. LAHUE SC, Gelfand AA, Bove RM
    Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?
    Neurology. 2019;93:668-672.
    PubMed     Text format     Abstract available

    Rev Neurol

  7. DOCTOROVICH ED, Martin-Bertuzzi F, Goicochea MT, Miranda S, et al
    [Argentinean consensus guidelines on the use of monoclonal antibodies in patients with migraine].
    Rev Neurol. 2020;70:149-158.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.